CorMedix (CRMD) Other financing activities (2010 - 2025)
CorMedix (CRMD) posted Other financing activities of $138808.0 for Q4 2025, up 182.18% sequentially from $49192.0 in Q3 2025, and up 107.34% YoY from $66947.3 in Q4 2024.
CorMedix (CRMD) Other financing activities (2010 - 2025) Analysis & Trends
CorMedix has reported Other financing activities for 13 years, with the latest figure at $138808.0 in Q4 2025.
- Quarterly Other financing activities rose 107.34% year-over-year to $138808.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (up 1117.44% YoY) and the FY2025 annual result came in at $188000.0, up 6166.67% from the prior year.
- Other financing activities improved to $138808.0 in Q4 2025 per CRMD's latest filing, from $49192.0 in the prior quarter.
- Over five years, Other financing activities peaked at $7.2 million in Q1 2023 and troughed at -$7.0 million in Q2 2023.
- A 4-year average of $145906.2 and a median of $49192.0 in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2021 and 2024: Other financing activities slumped 100.13% in 2021, then jumped 8440.0% in 2024.
- Over 4 years, Other financing activities stood at $27851.0 in 2021, then decreased by 28.19% to $20000.0 in 2023, then slumped by 9556.42% to -$1.9 million in 2024, then soared by 107.34% to $138808.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $138808.0, $49192.0, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138,808.00 |
| Dec 31, 2025 | 138,808.00 |
| Sep 30, 2025 | 49,192.00 |
| Sep 30, 2025 | 49,192.00 |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 350,350.00 |
| Mar 31, 2025 | 350,350.00 |
| Dec 31, 2024 | -1.89 Mn |
| Dec 31, 2024 | -1.89 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Sep 30, 2023 | 20,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | -6.97 Mn |
| Jun 30, 2023 | -6.97 Mn |
| Mar 31, 2023 | 7.20 Mn |
| Mar 31, 2023 | 7.20 Mn |
| Dec 31, 2021 | 27,851.00 |
| Dec 31, 2021 | 27,851.00 |